Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events (Q36729160)

15 August 2017

Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events (English)

1 reference

Lolkje T W de Jong-van den Berg

15 August 2017

6

object named as

Lolkje T W de Jong-van den Berg

1 reference

15 August 2017

2

Maarten J Postma

1 reference

15 August 2017

Cornelis Boersma

1

1 reference

15 August 2017

Sipke T Visser

3

1 reference

15 August 2017

Jarir Atthobari

4

1 reference

15 August 2017

Paul E de Jong

5

1 reference

15 August 2017

Ron T Gansevoort

7

1 reference

15 August 2017

PREVEND Study Group

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

30 January 2008

1 reference

British Journal of Clinical Pharmacology

15 August 2017

1 reference

15 August 2017

65

1 reference

15 August 2017

5

1 reference

15 August 2017

723-732

1 reference

Microalbuminuria as a target to improve cardiovascular and renal outcomes

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Inclusion of albuminuria in hypertension and heart guidelines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Inter-relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

+Microalbuminuria in hypertension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Pharmacy data in epidemiological studies: an easy to obtain and reliable tool

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Association between hyperlipidemia and microalbuminuria in essential hypertension.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Blood pressure, stroke, and coronary heart disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Asymmetric stratification. An outline for an efficient method for controlling confounding in cohort studies.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Cardiovascular Risk Factors Are Differently Associated with Urinary Albumin Excretion in Men and Women

28 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2008.03097.X

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2008.03097.X

A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2008.03097.X

Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2008.03097.X

Renal function, concomitant medication use and outcomes following acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2008.03097.X

The association between atherosclerotic risk factors and renal function in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2008.03097.X

Benefits and harms of drug treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2008.03097.X

Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2008.03097.X

Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2432483

Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population

20 October 2018

1 reference

12 December 2020

Microalbuminuria is related to marked end organ damage in previously untreated, elderly hypertensive patients

1 reference

12 December 2020

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

1 reference

12 December 2020

Practice Guidelines For Primary Care Physicians

1 reference

12 December 2020

Screening, monitoring, and treatment of albuminuria: Public health perspectives

1 reference

12 December 2020

Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications

1 reference

12 December 2020

10.1111/J.1365-2125.2008.03097.X

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

1 reference